窪蹋勛圖厙

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 窪蹋勛圖厙 News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

WHAT'S NEW

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, May 6 2026 9:05 AM

Full Issue

Feds Kept Favorable Studies On Covid, Shingles Vaccines Under Wraps, HHS Confirms

Scientists combed millions of patient records and determined that serious side effects from the covid and shingles shots are rare. The Trump administration withdrew the publication of those studies. Although HHS said "the authors drew broad conclusions that were not supported by the underlying data," career scientists who reviewed the drafts say the studies were well done.

Officials at the Food and Drug Administration have blocked publication of several studies supporting the safety of widely used vaccines against Covid-19 and shingles in recent months, a spokesman for the Department of Health and Human Services confirmed. The studies, which cost millions of dollars in public funds, were conducted by scientists at the agency, who worked with data firms to analyze millions of patient records. They found serious side effects to be very rare. (Jewett, 5/5)

In related news about covid

Sen. Rand Paul (R-Ky.) on Tuesday called for Anthony Fauci, former longtime director of the National Institute of Allergy and Infectious Diseases (NIAID), to be indicted for what the senator claimed was his lying under oath about gain-of-function research. 6 days from now, on May 11th, the statute of limitations expires on the possibility of indicting Anthony Fauci for denying under oath that he funded gain-of-function research involving bat coronaviruses in Wuhan, the origin city of the pandemic, Paul wrote on social media. (Choi, 5/5)

In other vaccine news about shingles, flu, and HPV

Older adults in the U.S. were less likely to develop dementia if they received the recombinant subunit zoster (shingles) vaccine (Shingrix), an analysis of 1.5 million Medicare beneficiaries showed. (George, 5/5)

Giving a respiratory syncytial virus (RSV) vaccine at the same time as a shingles vaccine produces a similar immune response as spacing the shots a month apart, according to a phase 3clinical trial published this week in Clinical Infectious Diseases. No safety concerns were identified with the co-administered vaccines. (Bergeson, 5/1)

A large, randomized study found no meaningful difference in protection between adjuvanted and high-dose flu vaccines for older adults during the 202324 flu season. The findings support the Advisory Committee on Immunization Practices (ACIP) recommendation that either formulation can be used for adults 65 years and older.(Bergeson, 5/5)

Twenty years after the approval of vaccines that prevent infection with the cancer-causing human papillomavirus (HPV), data continue to find that the shots are safe and extremely effective. HPV vaccines reduce the risk of cervical cancer by 80% in women vaccinated by age 16 years and 66% in those vaccinated after 16, and arent associated with serious side effects, according to an evidence review published today by the Vaccine Integrity Project (VIP), an initiative of the University of Minnesotas Center for Infectious Disease Research and Policy (CIDRAP), which publishes CIDRAP News. (Szabo, 5/5)

Tamika Felder always wanted a family. But her hopes for a future pregnancy were crushed when she was diagnosed with cervical cancer at age 25. It was the hardest thing Ive ever gone through, said Felder, now 50, whose treatment included radiation, chemotherapy, and a hysterectomy, in which the uterus is removed. I was glad I didnt die, but losing my fertility honestly felt like death. Vaccines that prevent infection with the human papillomavirus (HPV), which causes 90% of cervical cancers, werent available when Felder was a child.(Szabo, 5/5)

Also

They entered the world the way babies should, with piercing cries announcing their arrival. They passed their newborn screening tests. Some made it to their 2-week wellness visits without concern. Then, without warning, their systems began to shut down. A 7-week-old boy in Maryland developed sudden seizures. An 11-pound girl in Alabama stopped breathing for 20 seconds at a time. A baby boy in Kentucky vomited before becoming lethargic. A brown-haired girl in Texas, not yet 2 weeks old, bled around her belly button. (Eldeib, 5/6)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 窪蹋勛圖厙
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

穢 2026 KFF